![Marc Bozec](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc Bozec
Directeur Général chez
OSE IMMUNOTHERAPEUTICS
Profil
Marc Le Bozec is the founder of BioProtein Technologies SA, founded in 1998.
Mr. Bozec is currently the Chief Executive Officer at OSE Immunotherapeutics SA since 2025 and an Independent Director at Nicox SA since 2024.
Formerly, Director at CYTOO SA from 2013 to 2015.
Education includes an undergraduate degree from École des Hautes Études Commerciales de Paris.
Postes actifs de Marc Bozec
| Sociétés | Poste | Début |
|---|---|---|
| NICOX SA | Directeur/Membre du Conseil | 16/07/2024 |
| OSE IMMUNOTHERAPEUTICS | Directeur Général | 02/10/2025 |
Anciens postes connus de Marc Bozec
| Sociétés | Poste | Fin |
|---|---|---|
CYTOO SA
 CYTOO SA Medical SpecialtiesHealth Technology Operates as a contract research organization which develops physiological cell-based assays | Directeur/Membre du Conseil | 01/01/2015 |
BioProtein Technologies SA
 BioProtein Technologies SA BiotechnologyHealth Technology Develops recombinant therapeutic proteins and vaccines | Fondateur | - |
Formation de Marc Bozec
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Nicox SA
 Nicox SA Pharmaceuticals: MajorHealth Technology Manufactures and sells ophthalmology biopharmaceuticals | Health Technology |
BioProtein Technologies SA
BioProtein Technologies SA BiotechnologyHealth Technology Develops recombinant therapeutic proteins and vaccines | Health Technology |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CYTOO SA
CYTOO SA Medical SpecialtiesHealth Technology Operates as a contract research organization which develops physiological cell-based assays | Health Technology |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
